相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation
Malcolm Barrangou-Poueys-Darlas et al.
DRUG METABOLISM REVIEWS (2021)
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity
Carlotta Ciaramelli et al.
FOOD CHEMISTRY (2021)
Coffee polyphenols prevent cognitive dysfunction and suppress amyloid β plaques in APP/PS2 transgenic mouse
Keiko Ishida et al.
NEUROSCIENCE RESEARCH (2020)
Association between caffeine intake and cognitive function in adults; effect modification by sex: Data from National Health and Nutrition Examination Survey (NHANES) 2013-2014
Sohrab Iranpour et al.
CLINICAL NUTRITION (2020)
Parkinson disease
R. Balestrino et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Specific Nutritional Biomarker Profiles in Mild Cognitive Impairment and Subjective Cognitive Decline Are Associated With Clinical Progression: The NUDAD Project
Francisca A. de Leeuw et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)
The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease
Jiang-Fan Chen et al.
PURINERGIC SIGNALLING (2020)
Association of Coffee, Decaffeinated Coffee and Caffeine Intake from Coffee with Cognitive Performance in Older Adults: National Health and Nutrition Examination Survey (NHANES) 2011-2014.
Xue Dong et al.
NUTRIENTS (2020)
Coffee Consumption and C-Reactive Protein Levels: A Systematic Review and Meta-Analysis
Elizabeth D. Moua et al.
NUTRIENTS (2020)
Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson?s Disease in the Harvard Biomarkers Study
Rachit Bakshi et al.
JOURNAL OF PARKINSONS DISEASE (2020)
Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer's Disease
Liang Jin et al.
MOLECULAR PHARMACEUTICS (2020)
Adenosine A2A Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer's Disease
Rafael Franco et al.
CELLS (2020)
A Matter of Choice: Inhibition of c-Rel Shifts Neuronal to Oligodendroglial Fate in Human Stem Cells
Lucia Mercedes Ruiz-Perera et al.
CELLS (2020)
Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology
Laura C. Maclagan et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)
Amyloid beta (1-42) downregulates adenosine-2b receptors in addition to mitochondrial impairment and cholinergic dysfunction in memory-sensitive mouse brain regions
Bhupesh Chandra Semwal et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2020)
EEF1A1 deacetylation enables transcriptional activation of remyelination
Mert Duman et al.
NATURE COMMUNICATIONS (2020)
Effects of Habitual Caffeine Intake, Physical Activity Levels, and Sedentary Behavior on the Inflammatory Status in a Healthy Population
Lluis Rodas et al.
NUTRIENTS (2020)
The Effect of Caffeine on the Risk and Progression of Parkinson's Disease: A Meta-Analysis
Chien Tai Hong et al.
NUTRIENTS (2020)
The Effects of Resveratrol, Caffeine, β-Carotene, and Epigallocatechin Gallate (EGCG) on Amyloid-β25-35 Aggregation in Synthetic Brain Membranes
Isabella P. Gastaldo et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2020)
Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers A metabolomic study
Grace F. Crotty et al.
NEUROLOGY (2020)
Genomics in Personalized Nutrition: Can You Eat for Your Genes?
Veronica A. Mullins et al.
NUTRIENTS (2020)
Coffee consumption is not associated with risk of multiple sclerosis: A Mendelian randomization study
Hui Lu et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer's and Parkinson's Disease: Insight into the Role of Nrf-2 and A2AR Signaling
Muhammad Ikram et al.
ANTIOXIDANTS (2020)
Caffeine inhibits Notum activity by binding at the catalytic pocket
Yuguang Zhao et al.
COMMUNICATIONS BIOLOGY (2020)
Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells
Daniel Janitschke et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale
Owen Sanders et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2020)
The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making
Marta Pardo et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Neuroprotective and Neurodegenerative Aspects of Coffee and Its Active Ingredients in View of Scientific Literature
Shehnaz Wasim et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
A punch in the gut - Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease
Anouck Becker et al.
PARKINSONISM & RELATED DISORDERS (2019)
LRRK2 links genetic and sporadic Parkinson's disease
Jillian H. Kluss et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Synthesis, biological evaluation and molecular modelling studies of 1,3,7, 8-tetrasubstituted xanthines as potent and selective A2A AR ligands with in vivo efficacy against animal model of Parkinson's disease
Suman Rohilla et al.
BIOORGANIC CHEMISTRY (2019)
Caffeine Modulates Cadmium-Induced Oxidative Stress, Neuroinflammation, and Cognitive Impairments by Regulating Nrf-2/HO-1 In Vivo and In Vitro
Amjad Khan et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice
Jiayi Zhao et al.
SCIENTIFIC REPORTS (2019)
Caffeine Consumption During Pregnancy Accelerates the Development of Cognitive Deficits in Offspring in a Model of Tauopathy
Stefania Zappettini et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Coffee intake and decreased amyloid pathology in human brain
Jee Wook Kim et al.
TRANSLATIONAL PSYCHIATRY (2019)
Effect of Caffeine and Other Methylxanthines on Aβ-Homeostasis in SH-SY5Y Cells
Daniel Janitschke et al.
BIOMOLECULES (2019)
Caffeine May Abrogate LPS-Induced Oxidative Stress and Neuroinflammation by Regulating Nrf2/TLR4 in Adult Mouse Brains
Haroon Badshah et al.
BIOMOLECULES (2019)
Computational and In-Vitro Validation of Natural Molecules as Potential Acetylcholinesterase Inhibitors and Neuroprotective Agents
Ashwani Kumar et al.
CURRENT ALZHEIMER RESEARCH (2019)
Multiple sclerosis - a review
R. Dobson et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Caffeine destabilizes preformed Aβ protofilaments: insights from all atom molecular dynamics simulations
Shivani Gupta et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2019)
Synthesis and Biological Evaluation of Structurally Varied 5′-/6′-Isonucleosides and Theobromine-Containing N-Isonucleosidyl Derivatives
Nuno M. Xavier et al.
PHARMACEUTICALS (2019)
Effects of Long-Term Caffeine Consumption on the Adenosine A1 Receptor in the Rat Brain: an In Vivo PET Study with [18F]CPFPX
Danje Nabbi-Schroeter et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Istradefylline reduces memory deficits in aging mice with amyloid pathology
Anna G. Orr et al.
NEUROBIOLOGY OF DISEASE (2018)
Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
Motoki Fujimaki et al.
NEUROLOGY (2018)
A novel pharmacological activity of caffeine in the cholinergic system
Camila Fabiani et al.
NEUROPHARMACOLOGY (2018)
Prospective Associations between Single Foods, Alzheimer's Dementia and Memory Decline in the Elderly
Karina Fischer et al.
NUTRIENTS (2018)
Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease
Emilie Faivre et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Chronic Caffeine Treatment Protects Against α-Synucleinopathy by Reestablishing Autophagy Activity in the Mouse Striatum
Yanan Luan et al.
FRONTIERS IN NEUROSCIENCE (2018)
Roasted Coffee Reduces β-Amyloid Production by Increasing Proteasomal β-Secretase Degradation in Human Neuroblastoma SH-SY5Y Cells
Kazuya Fukuyama et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson's disease
Takuma Ohmichi et al.
PLOS ONE (2018)
HPLC Method for Quantification of Caffeine and Its Three Major Metabolites in Human Plasma Using Fetal Bovine Serum Matrix to Evaluate Prenatal Drug Exposure
Rosa del Carmen Lopez-Sanchez et al.
JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY (2018)
Coffee Consumption and Risk of Dementia and Alzheimer's Disease: A Dose-Response Meta-Analysis of Prospective Studies
Susanna C. Larsson et al.
NUTRIENTS (2018)
Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation
Ross S. Mancini et al.
FRONTIERS IN NEUROSCIENCE (2018)
Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model
Jesus Mendiola-Precoma et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Theobromine up-regulates cerebral brain-derived neurotrophic factor and facilitates motor learning in mice
Mitsugu Yoneda et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
The effect of istradefylline for Parkinson's disease: A meta-analysis
Wataru Sako et al.
SCIENTIFIC REPORTS (2017)
Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview
S. C. Yenisetti et al.
AIMS PUBLIC HEALTH (2016)
Monomeric C-reactive protein-a key molecule driving development of Alzheimer's disease associated with brain ischaemia?
M. Slevin et al.
SCIENTIFIC REPORTS (2015)
Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors
Lena Aronsen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
The emerging role of nutrition in Parkinson's disease
Stacey E. Seidl et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background
Kenghoe Lok et al.
NEUROSCIENCE LETTERS (2013)
Intake of Japanese and Chinese teas reduces risk of Parkinson's disease
Keiko Tanaka et al.
PARKINSONISM & RELATED DISORDERS (2011)
Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats
Guo Qian Chen et al.
BRAIN RESEARCH (2010)
Caffeine Suppresses Amyloid-β Levels in Plasma and Brain of Alzheimer's Disease Transgenic Mice
Chuanhai Cao et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice
Gary W. Arendash et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice
Oscar P. Dall'Igna et al.
EXPERIMENTAL NEUROLOGY (2007)
Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats
P. Dazert et al.
NEUROSCIENCE (2006)
Risk factors for Alzheimer's disease:: A prospective analysis from the Canadian Study of Health and Aging
J Lindsay et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
A Ascherio et al.
ANNALS OF NEUROLOGY (2001)
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada
SL Tyas et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2001)
Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease
JF Chen et al.
JOURNAL OF NEUROSCIENCE (2001)
分享论文
